<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) cells are malignant counterparts of germinal centre (GC) B cells </plain></SENT>
<SENT sid="1" pm="."><plain>Microenvironment of FL B cells has an important role in the progression of FL and might also have an impact on the treatment of FL </plain></SENT>
<SENT sid="2" pm="."><plain>CD40 is an important mediator of microenvironmental survival signals in GCs </plain></SENT>
<SENT sid="3" pm="."><plain>Here we studied responses of CD40 signalling on TRAIL-, <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>- and <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in three human FL cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>In two of the FL cell lines, CD40 protected cells from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> which was entirely dependent on the activation of NF-kappaB </plain></SENT>
<SENT sid="5" pm="."><plain>In one of the FL cell lines, CD40 induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> itself </plain></SENT>
<SENT sid="6" pm="."><plain>However, inhibition of NF-kappaB induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> three FL cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, our results indicate that inhibitors of NF-kappaB or critical downstream anti-apoptotic targets of NF-kappaB instead of blocking CD40 antibodies in combination with TRAIL or other cytotoxic agents should be considered in the treatment of FL in order to prevent the protective effect of the microenvironment </plain></SENT>
</text></document>